A new marker, SOX11, aids the diagnosis of mantle cell lymphoma in the prostate: A case report
- Authors:
- Binghai Chen
- Guangming Yin
- Lujing Duan
- Wanmeng Li
- Xianzhen Jiang
View Affiliations
Affiliations: Department of Urology, Third Xiang-Ya Hospital of Central South University, Yuelu, Changsha 410000, P.R. China, Department of Endocrinology, Affiliated Hospital of Jiangsu University, Jingkou, Zhenjiang 210000, P.R. China, Department of Radiology, Third Xiang-Ya Hospital of Central South University, Yuelu, Changsha 410000, P.R. China
- Published online on: May 25, 2012 https://doi.org/10.3892/ol.2012.732
-
Pages:
265-267
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Mantle cell lymphoma (MCL) of the prostate, either primary or secondary, is a rare entity. This case report examines an 83-year-old male who complained of not only nocturia (2-3 times), but also frequency and urgency of urination. The maximal urinary flow rate was 4.1 ml/sec. A transrectal ultrasound-guided prostate biopsy was advised after a hard enlargement of the prostate was detected; however, it was refused. Therefore, a plasma kinetic transurethral resection of the prostate was performed. Postoperative pathological examinations demonstrated MCL of the prostate. Positive immunohistochemistry for CD5 and cyclin D1 was observed. The diagnosis was confirmed by the introduction of a new diagnostic marker, SOX11. The maximal flow rate achieved was 15 ml/sec following surgery. To the best of our knowledge, this is the first study of MCL being diagnosed using SOX11 as a marker in the prostate. This case should alert clinicians and pathologists to pay close attention to the diagnosis of malignant lymphoma of the prostate. This study provides further insights into the diagnosis and therapy of MCL.
View References
|
1
|
Sander B: Mantle cell lymphoma: recent
insights into pathogenesis, clinical variability, and new
diagnostic markers. Semin Diagn Pathol. 28:245–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Abdussalam A and Gerridzen RG: Mantle cell
lymphoma of the prostate. Can Urol Assoc J. 3:E94–E95.
2009.PubMed/NCBI
|
|
3
|
Genkin I: Mantle cell lymphoma of
prostate. Commun Oncol. 3:692006. View Article : Google Scholar
|
|
4
|
Chim CS, Loong F, Yau T, Ooi GC and Liang
R: Common malignancies with uncommon sites of presentation: case 2.
Mantle-cell lymphoma of the prostate. J Clin Oncol. 21:4456–4458.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abrahamsson A, Dahle N and Jerkeman M:
Marked improvement of overall survival in mantle cell lymphoma: a
population based study from the Swedish Lymphoma Registry. Leuk
Lymphoma. 52:1929–1935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Smedby KE and Hjalgrim H: Epidemiology and
etiology of mantle cell lymphoma and other non-Hodgkin lymphoma
subtypes. Semin Cancer Biol. 21:293–298. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yatabe Y, Suzuki R, Tobinai K, et al:
Significance of cyclin D1 overexpression for the diagnosis of
mantle cell lymphoma: a clinicopathologic comparison of cyclin
D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma.
Blood. 95:2253–2261. 2000.PubMed/NCBI
|
|
8
|
Ek S, Dictor M, Jerkeman M, Jirström K and
Borrebaeck CA: Nuclear expression of the non B-cell lineage Sox11
transcription factor identifies mantle cell lymphoma. Blood.
111:800–805. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu W and Li JY: SOX11 expression in mantle
cell lymphoma. Leuk Lymphoma. 51:1962–1967. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Le Gouill S, Mohty M, Guillaume T,
Gastinne T and Moreau P: Allogeneic stem cell transplantation in
mantle cell lymphoma: where are we now and which way should we go?
Semin Hematol. 48:227–239. 2011.PubMed/NCBI
|
|
11
|
Dietrich S, Tielesch B, Rieger M, et al:
Patterns and outcome of relapse after autologous stem cell
transplantation for mantle cell lymphoma. Cancer. 117:1901–1910.
2011. View Article : Google Scholar : PubMed/NCBI
|
